EBITDA Margin Falls to 6.6% as Mahad Ramp Drags

Oriental Aromatics Limited — Q4 & FY’26 Earnings Call (21 May 2026)

1. Overall Tone of Management: Neutral

• Management highlights a positive top-line milestone (“crossed the INR 1,000 crore revenue mark… INR 1,030 crores… ~11% growth”) and healthy volume growth.
• However, they repeatedly emphasize margin pressure and worsening near-term input/currency conditions (“situation will worsen before we can see some normalcy”; FY’26 EBITDA margin down to 6.60% from 10.06%; PAT down sharply).
• Outlook language is cautiously constructive (“positive… optimistic but realistic… worst is still not over”) rather than strongly confident.

2. Key Themes from Management Commentary

• Growth despite tough pricing/demand:
• Q4 sales volume +16% QoQ and +5% YoY; FY’26 sales volume +9% YoY.
• They attribute resilience to diversified portfolio and customer relationships.
• Margin compression driven by multi-factor cost shocks + Mahad ramp-up:
• FY’26 EBITDA margin 6.60% vs 10.06% (FY’25).
• Causes cited: pricing pressure, raw material inflation, INR depreciation, and Mahad drag (consolidated EBITDA margin drag ~1% to 1.5%).
• Aroma Ingredients: buyer market + China capacity overhang:
• “Capacities built up by Chinese players… continue to flow… keeping end product pricing… subdued.”
• Input cost “triple shock” at all-time highs:
• Gum turpentine, CST, alpha-pinene at all-time highest ever, plus crude volatility and rupee depreciation.
• Mahad ramp-up progressing but still a profitability drag:
• Sampling cycles completed; “commercial shipments have commenced.”
• They guide EBITDA neutrality at 75–80% utilization within ~next one year.
• Tariff overhang easing / RFQs constructive:
• “Tariffs overhang… has eased… should support a gradual recovery in order flow from North America.”
• RFQ cycles for H2 FY’26 “looking constructive on volumes though pricing continues to remain tight.”
• Strategic stance: consolidation/profit preservation over expansion:
• “Consolidation mode… profit preservation and growth with our current assets is the underlying theme.”

3. Q&A Analysis

Theme A: Camphor imports, anti-dumping, and GST/gray-market issues

• Core questions
• Steps taken to counter natural camphor imports from China (anti-dumping duty / ban / government memorandum).
• Whether company is addressing camphor availability without GST harming billing/compliance.
• Management response
• Government dialogue: “initiated a dialogue… twice… will update you.”
• Observed change: “imports from China have decreased considerably… rate of natural camphor in China has also increased.”
• GST/gray-market: refused to comment on alleged bypassing (“we cannot comment on them”).
• Assessment
• Partial/evasive on GST issue (deflection to compliance stance).
• No concrete policy action (no confirmation of filing/anti-dumping participation), only “dialogue” and monitoring.

Theme B: Mahad economics, utilization, capex, and EBITDA neutrality

• Core questions
• Peak revenue at full capacity (with/without Mahad).
• CAPEX spent and expected revenue/asset turn.
• When Mahad becomes EBITDA neutral; utilization threshold.
• Management response
• Peak revenue: guided range INR 1200–1250 crores (excluding Mahad ramp-up), and ~INR 50 crores additional revenue at current capacity.
• EBITDA neutrality: “next one year… utilization 75% to 80%… should make it EBITDA neutral and start contributing.”
• CAPEX: initially “~INR 90 crore approx.” then clarified split:
  • Plant-specific investment ~INR 70–75 crore (with utilities/expandable base ~INR 20–25 crores).
• Utilization/EBITDA: earlier calls implied EBITDA drag; in this call they reiterate drag 1%–1.5% and provide the utilization path to neutrality.
• Assessment
• Strong on direction (utilization-based plan) but numbers shift due to clarification (INR 90 crore vs plant-specific 70–75 crore).
• Some conservatism: “conservative basis” for Evermoss revenue assumptions.

Theme C: Margins vs peers; FY’27 margin recovery

• Core questions
• Why EBITDA margins are ~6% vs peers (15–20%).
• Can margins return to ~10% in FY’27?
• Management response
• Blames industry-wide ingredient price turbulence and Mahad drag.
• Explains structural difference: they are a long-term global player in aroma ingredients (investment cycle).
• FY’27: “endeavor to go back to the guided number of around 10%… worst is still not over.”
• Assessment
• Unusually candid admission: “worst is still not over.”
• Still no hard commitment; uses “endeavor/positive/realistic.”

Theme D: Working capital / receivables / inventory

• Core questions
• Why trade receivables up ~40% and MSME dues up; any payment issues?
• Is inventory increasing due to price/availability strategy?
• Management response
• Receivables: customers are “top class”; extended credit periods; prices adjusted to cover cost of money.
• Inventory: they “overstocked” due to availability challenges in some petro streams; inventory increase likely strategic.
• MSME: buying increased; “no problem.”
• Assessment
• Defensive but coherent: attributes receivables to credit terms and inventory to supply risk.
• No quantified working-capital metrics provided beyond qualitative explanations.

Theme E: Pricing pass-through and lag

• Core questions
• How much of all-time-high input increases are passed to customers; lag in pass-through.
• Management response
• Pass-through: price increases 25%–27%, implemented in 3-month incrementals due to buyer resistance.
• Spot: monthly price lists for instant pass-through.
• Assessment
• Relatively strong and specific on pass-through mechanics and timing.

Theme F: Differentiation vs China in export markets

• Core questions
• Differentiation beyond pricing in Europe/South Africa amid Chinese oversupply.
• Management response
• Multi-point differentiation: backward integration, process optimization via shared infrastructure, and product basket breadth.
• Assessment
• Strategic narrative; no hard evidence/metrics, but consistent with earlier “value proposition” framing.

Theme G: FY’27 revenue outlook

• Core questions
• Topline growth expectations for FY’27.
• Management response
• Refuses numeric guidance: “crystal ball question… cannot then back it up.”
• Emphasizes balancing growth with profit preservation and avoiding demand destruction via excessive pricing.
• Assessment
• Evasive on numbers; consistent with prior conservatism.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Mahad EBITDA neutrality:
• “In the next one year… utilization 75% to 80%… should be EBITDA neutral and start contributing.”
• Mahad revenue contribution:
• “At the current capacity, it will be around INR 50 crores additional revenue.”
• Peak revenue potential (range):
• “anywhere between INR 1200 crores to INR 1250 crores” (max turnover at peak capacity, excluding Mahad ramp-up).
• FY’26 margin baseline:
• EBITDA margin 6.60% (reported), not guidance.
• Dividend:
• Final dividend INR 0.50 per equity share (subject to AGM approval).

Implicit signals (qualitative)

• Pricing remains tight: “pricing continues to remain tight” (H2 RFQs).
• Input cost pressure persists: “situation will worsen before… normalcy.”
• Tariff overhang easing: gradual North America order recovery expected.
• Strategy: “consolidation… profit preservation… rebuild margins structurally… independent of pricing cycle turning.”

5. Standout Statements (direct / highly revealing)

• Cost shock severity: “gum turpentine, CST and alpha-pinene prices… at their all-time highest ever.”
• Near-term outlook caution: “We are of the opinion that the situation will worsen before we can see some normalcy.”
• Mahad drag quantified: “Mahad… drag on our consolidated EBITDA margins to the extent of between 1% to 1.5%.”
• Margin recovery stance: “endeavor to go back to… around 10%… worst is still not over.”
• Mahad commercialization progress: “commercial shipments have commenced… qualified to submit bids for certain global RFQs… second half of 2026.”
• Pricing pass-through mechanics: “price increase of anywhere between 25% to 27%… broken… into incrementals of three months.”
• Working capital explanation: receivables rise due to “extended credit period… prices adjusted to ensure… cost of money… covered.”

6. Red Flags / Positive Signals

Red flags
– No hard FY’27 revenue guidance (“crystal ball question”).
– Repeated emphasis that headwinds take “a few quarters” and that the situation may worsen—suggests margin recovery timing risk.
– Margin recovery framed as “endeavor” rather than commitment.
– Working capital increase (receivables + MSME dues) not fully quantified; relies on qualitative assurances.

Positive signals
– Volume growth resilience despite pricing pressure (Q4 and FY’26 volumes up).
– Mahad progress is tangible (sampling completed, commercial shipments started, RFQ qualification).
– Clear pass-through strategy (3-month incrementals; monthly spot price lists).
– Balance sheet comfort: net debt/equity 0.58x and “comfortable leverage.”

7. Historical Comparison & Consistency Analysis (vs prior 3 calls)

a. Change in Tone Over Time

• Q2 FY’26 (Nov 2025): more confident on margin restoration—target “restore margins to 8% to 10%” as Mahad stabilizes.
• Q3 FY’26 (Feb 2026): still cautiously optimistic; emphasized “trend is reassuring” and expected margin improvement as Mahad stabilizes.
• Q4 & FY’26 (May 2026): tone becomes more cautious on costs:
• Adds stronger language: “situation will worsen” and “worst is still not over.”
• Margin recovery remains “endeavor,” not a firm path.
• Classification shift: More Cautious (from “restore margins” to “endeavor” + explicit worsening cost environment).

b. Tracking Past Commitments vs Outcomes

• Past statement (Q2 FY’26): Mahad drag expected to normalize “over the next few quarters” and margin target “8% to 10%.”
• What expected: normalization and margin recovery as ramp progresses.
• What happened by FY’26: EBITDA margin fell to 6.60% (from 10.06% in FY’25); PAT collapsed to INR 3.3 crore.
• Flag: ⏳ Delayed / Not achieved (normalization did not translate into margin recovery by FY’26).
• Past statement (Q3 FY’26): Mahad stabilization would reduce drag progressively; focus on rebuilding margins structurally.
• What happened: drag persists; FY’26 still shows major profitability decline.
• Flag: ⏳ Delayed (structural rebuild benefits pushed to FY’27: “accrue progressively as we move through FY’27.”)

c. Narrative Shifts

• From tariff optimism to cost shock realism:
• Earlier calls leaned on tariff/trade deal uncertainty easing as a catalyst for sales and profitability.
• Current call shifts emphasis to input cost “triple shock” and currency depreciation as the dominant driver.
• Mahad narrative becomes more operationally specific (sampling cycles, commercial shipments, RFQ bids), but profitability impact remains unresolved.
• FMCG/retail discussion fades:
• In Q3 FY’26, investors pressed for FMCG strategy details; management was guarded.
• In Q4 FY’26, FMCG is mentioned mainly as part of camphor retail footprint, with less detail.

d. Consistency & Credibility Signals

• Credibility: Medium
• Consistent: Mahad ramp-up drag is repeatedly cited; utilization-based path is maintained.
• Inconsistent/weak: margin recovery expectations (“8–10%”) have not materialized by FY’26; management now frames recovery as “endeavor” and adds “worst is still not over.”
• Working capital explanations are consistent in spirit (inventory/credit terms), but lack quantified transparency.

e. Evolution of Key Themes

• Demand/volumes: Improving/Stable (volumes consistently growing YoY).
• Margins: Deteriorating through FY’26 (EBITDA margin down from FY’25 10.06% to FY’26 6.60%).
• China oversupply: Stable narrative—still a buyer market; pricing subdued.
• Mahad: Progressing operationally, but profitability timeline pushed to utilization 75–80% and “next one year.”

f. Additional Insights (cross-period intelligence)

• Margin decline is not solely “pricing cycle”: management now explicitly attributes worsening to all-time-high inputs + rupee depreciation, implying even if pricing stabilizes, margins may remain pressured longer.
• Mahad profitability timing risk remains high: they provide a utilization threshold, but earlier calls suggested normalization “over the next few quarters,” which did not occur by FY’26.
• Management is increasingly careful with forward-looking numbers (no FY’27 revenue guidance), suggesting uncertainty in translating volume growth into profitability.